Exercise, Cognitive Function and Neuroplasticity in Healthy Adults
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 70 |
Updated: | 12/15/2018 |
Start Date: | September 29, 2017 |
End Date: | January 1, 2022 |
Contact: | Joyce R Gomes Osman, PT, PhD |
Email: | j.gomes@miami.edu |
Phone: | 305-284-2632 |
The overall goal of the proposed study is to compare the effects of 4 weeks of moderate or
high intensity aerobic exercise on neuroplasticity, cognitive performance and gait and
postural control in sedentary healthy adults.
high intensity aerobic exercise on neuroplasticity, cognitive performance and gait and
postural control in sedentary healthy adults.
The primary aim of the study is to compare the effects of a moderate intensity aerobic
exercise intervention (delivered at 55-64% age-predicted maximal heart rate) with a high
intensity aerobic exercise intervention (delivered at 65%-90% age-predicted maximal heart
rate) on measures that probe cortical synaptic plasticity using transcranial magnetic
stimulation (TMS) in sedentary healthy adults.
exercise intervention (delivered at 55-64% age-predicted maximal heart rate) with a high
intensity aerobic exercise intervention (delivered at 65%-90% age-predicted maximal heart
rate) on measures that probe cortical synaptic plasticity using transcranial magnetic
stimulation (TMS) in sedentary healthy adults.
Inclusion Criteria:
- Adult males and females aged 18-60 years old
- Primary language is English
- Sedentary (defined as not engaging in purposeful physical activity more than 2 times
over the last two months)
- Exercise clearance
Exclusion Criteria:
- Presence of cognitive, neurologic or orthopedic conditions that could affect
performance of the testing and training procedures
- History of migraines.
- History of fainting spells of unknown or undetermined etiology that might constitute
seizures
- History of seizures, diagnosis of epilepsy, history of abnormal (epileptiform) EEG or
family history of treatment resistant epilepsy
- Any current history of a psychiatric illness
- Any unstable medical condition
- No medication is an absolute exclusion from TMS. Medications will be reviewed by the
Principal Investigator and a decision about inclusion will be made based on the
following:
- The subject's past medical history, drug dose, history of recent medication
changes or duration of treatment, and combination with other CNS active drugs.
- The published TMS guidelines review medications to be considered with TMS (Rossi,
Hallett, Rossini, Pascual-Leone, & Safety of TMS Consensus Group, 2009).
- Any metal in the brain, skull or elsewhere unless approved by the responsible MD
- Any medical devices (i.e. Cardiac pacemaker, deep brain stimulator, medication
infusion pump, cochlear implant, vagal nerve stimulator)
- Intracranial lesion
- Substance abuse or dependence within the past six months Subjects who, in the
Investigator's opinion, might not be suitable for the study
We found this trial at
1
site
1601 Northwest 12th Avenue
Miami, Florida 33136
Miami, Florida 33136
(305) 243-6545
Phone: 305-284-2632
University of Miami Miller School of Medicine The University of Miami Leonard M. Miller School...
Click here to add this to my saved trials